Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease - PubMed (original) (raw)

Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease

Yun-Jung Kang. Disaster Med Public Health Prep. 2020 Jun.

Abstract

On December 31, 2019 the China National Health Commission (NHC) reported that an unknown cause of pneumonia had been detected in Wuhan in Hubei province. On February 12, the disease caused by the novel coronavirus (2019-nCoV) was given a formal name, COVID-19. On January 20, 2020, the first case of COVID-19 was confirmed in Korea. The age-specific death rate was the highest among patients over 70 years of age, with underlying diseases in their circulatory system, such as myocardial infarction, cerebral infraction, arrythmia, and hypertension. Patients with underlying disease who are 70 years of age or older should recognize that there is a high possibility of developing a serious disease in case of viral infection and follow strict precautions.

Keywords: COVID-19; mortality rate; over 70; perspective; prevention; underlying diseases.

PubMed Disclaimer

Similar articles

• Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020.
  Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention. Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention. J Korean Med Sci. 2020 Mar 30;35(12):e132. doi: 10.3346/jkms.2020.35.e132. J Korean Med Sci. 2020. PMID: 32233161 Free PMC article.
• Disparities in Age-specific Morbidity and Mortality From SARS-CoV-2 in China and the Republic of Korea.
  Dudley JP, Lee NT. Dudley JP, et al. Clin Infect Dis. 2020 Jul 28;71(15):863-865. doi: 10.1093/cid/ciaa354. Clin Infect Dis. 2020. PMID: 32232322 Free PMC article.
• Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.
  Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, Guo GY, Du J, Zheng CL, Zhu Q, Hu M, Li XY, Peng P, Shi HZ. Du RH, et al. Eur Respir J. 2020 May 7;55(5):2000524. doi: 10.1183/13993003.00524-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32269088 Free PMC article.
• At the heart of COVID-19.
  Khan IH, Zahra SA, Zaim S, Harky A. Khan IH, et al. J Card Surg. 2020 Jun;35(6):1287-1294. doi: 10.1111/jocs.14596. Epub 2020 May 5. J Card Surg. 2020. PMID: 32369872 Review.
• Health related factors contributing to COVID-19 fatality rates in various communities across the world.
  Shakor JK, Isa RA, Babakir-Mina M, Ali SI, Hama-Soor TA, Abdulla JE. Shakor JK, et al. J Infect Dev Ctries. 2021 Sep 30;15(9):1263-1272. doi: 10.3855/jidc.13876. J Infect Dev Ctries. 2021. PMID: 34669594 Review.

Cited by

• Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
  Bajgain KT, Badal S, Bajgain BB, Santana MJ. Bajgain KT, et al. Am J Infect Control. 2021 Feb;49(2):238-246. doi: 10.1016/j.ajic.2020.06.213. Epub 2020 Jul 10. Am J Infect Control. 2021. PMID: 32659414 Free PMC article.
• Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.
  Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A. Price E, et al. Clin Med (Lond). 2020 May 15;20(3):256-261. doi: 10.7861/clinmed.2020-0149. Print 2020 May 5. Clin Med (Lond). 2020. PMID: 32371418 Free PMC article.
• Fatality Rate and Survival Time of Laboratory-Confirmed COVID-19 for Patients in England During the First Wave of SARS-CoV-2 Infection: A Modelling Study.
  Hillyar CR, Nibber A, Jones CE, Jones MG. Hillyar CR, et al. Cureus. 2021 Aug 5;13(8):e16899. doi: 10.7759/cureus.16899. eCollection 2021 Aug. Cureus. 2021. PMID: 34513472 Free PMC article.
• Deterioration of mental health despite successful control of the COVID-19 pandemic in South Korea.
  Lee HS, Dean D, Baxter T, Griffith T, Park S. Lee HS, et al. Psychiatry Res. 2021 Jan;295:113570. doi: 10.1016/j.psychres.2020.113570. Epub 2020 Nov 13. Psychiatry Res. 2021. PMID: 33234326 Free PMC article.
• Prognostic comparison of COVID-19 outpatients and inpatients treated with Remdesivr: A retrospective cohort study.
  Zamani S, Alizadeh M, Shahrestanaki E, Mohammadpoor Nami S, Qorbani M, Aalikhani M, Hassani Gelsefid S, Mohammadian Khonsari N. Zamani S, et al. PLoS One. 2022 Nov 10;17(11):e0277413. doi: 10.1371/journal.pone.0277413. eCollection 2022. PLoS One. 2022. PMID: 36356035 Free PMC article.

References

1. 1. Hyun JH, Kim JH, Lee HY, et al. Contact tracing results of the first confirmed COVID-19 case in the Republic of Korea. Public Health Weekly Report, Korean Centers for Disease Control and Prevention. 2020;13(7):352-358. https://www.cdc.go.kr/board/board.es?mid=a30501000000&bid=0031&list_no=3.... Accessed March 31, 2020.
2. 1. Kim NS, Coronavirus Infection-19 status and challenges. Health and Welfare Issue&Focus 2020;373:1–13. doi: http://repository.kihasa.re.kr/bitstream/201002/34380/8/%ec%9d%b4%ec%8a%.... Accessed March 31, 2020.
3. 1. Gu GI, Jo YR. “Corona 19, has a decisive move”… WHO’s warning. Dong A; February 28, 2020. [cited March 16, 2020]. http://www.donga.com/news/List/article/all/20200228/99928838/1(Korean).
4. 1. Korea Centers for Disease Control and Prevention; March 7, 2020 [cited March 16, 2020]. http://ncov.mohw.go.kr/tcmBoardView.do?brdId=&brdGubun=&dataGubun=&ncvCo... (Korean).
5. 1. Heyland DK, Frank C, Groll D, et al. Understanding cardiopulmonary resuscitation decision making: perspectives of seriously ill hospitalized patients and family members. Chest. 2006;130:419-428. - PubMed

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Cambridge University Press
  • Europe PubMed Central
  • PubMed Central